- $4.07m
- -$4.15m
Annual balance sheet for Genprex, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | C2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Short Term Investments | 2 | 27.3 | 38.6 | 21 | 6.74 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.001 | 0 | 0 | 0.035 | 0 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Current Assets | 2.98 | 27.7 | 39.1 | 21.5 | 7.53 |
Net Property, Plant And Equipment | 0.045 | 0.039 | 0.049 | 0.023 | 0.008 |
Net Intangible Assets | |||||
Other Long Term Assets | |||||
Total Assets | 3.53 | 31.4 | 42.9 | 25.1 | 10.7 |
Accounts Payable | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 0.511 | 0.451 | 1.59 | 2.81 | 3.25 |
Total Long Term Debt | |||||
Total Debt | |||||
Total Liabilities | 0.511 | 0.451 | 1.59 | 2.81 | 3.25 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 3.02 | 30.9 | 41.3 | 22.3 | 7.42 |
Total Liabilities & Shareholders' Equity | 3.53 | 31.4 | 42.9 | 25.1 | 10.7 |
Total Common Shares Outstanding |